Colorectal cancer

CRC · Oncology · 2 drugs · 2 indications

Cancer of the colon or rectum. Includes MSI-high and MSS subtypes.

Competitive Landscape (2 drugs)

Drug	Company	Mechanism	Modality	Route	Stage
Avastin	ROG.SW	VEGF antagonist	Antibody	IV	APPROVED
Vectibix	AMGN	EGFR inhibitor (monoclonal antibody)	Monoclonal antibody	IV	APPROVED

Indications (2)

Wild-type RAS metastatic colorectal cancer

Vectibix APPROVED

mCRC

Avastin APPROVED

Data from Supabase · Updated 2026-03-24